AMA1-C1/Alhydrogel + CpG 7909

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HVHealthy VolunteerMalaria

Phase 1

Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)

CompletedNCT00340574

National Institute of Allergy and Infectious Diseases (NIAID)Healthy Volunteer, HV

Start: 2005-03-08End: 2008-07-02Updated: 2017-07-02

Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine

CompletedNCT00427167

National Institute of Allergy and Infectious Diseases (NIAID)Malaria

Start: 2007-01-23End: 2008-11-05Target: 300Updated: 2017-07-02